Molecular Detection is developing and commercializing a portfolio of sample-to-answer Detect-Ready™ molecular diagnostic tests for detection of infectious diseases. Our first product is a ready-to-use rapid detection DNA-based screening test for MRSA infection that was recently launched in the European Union. It offers the advantages of increased accuracy, faster time to results and more efficient utilization of hospital resources compared to current and emerging MRSA diagnostic products. MDI’s tests are based on novel patent-pending technologies for differential diagnosis, chemistry and for room temperature stabilization of the kit.